2024-06-152025-03-312025-03-31false15779737SCULPTCLINIC LTD2025-12-2286210falseiso4217:GBPxbrli:pure157797372024-06-14157797372025-03-31157797372024-06-152025-03-31157797372024-06-13157797372024-06-14157797372024-06-142024-06-1415779737bus:SmallEntities2024-06-152025-03-3115779737bus:AuditExempt-NoAccountantsReport2024-06-152025-03-3115779737bus:FullAccounts2024-06-152025-03-3115779737bus:PrivateLimitedCompanyLtd2024-06-152025-03-3115779737core:WithinOneYear2025-03-3115779737core:AfterOneYear2025-03-3115779737core:WithinOneYear2024-06-1415779737core:AfterOneYear2024-06-1415779737core:ShareCapital2025-03-3115779737core:SharePremium2025-03-3115779737core:RevaluationReserve2025-03-3115779737core:OtherReservesSubtotal2025-03-3115779737core:RetainedEarningsAccumulatedLosses2025-03-3115779737core:ShareCapital2024-06-1415779737core:SharePremium2024-06-1415779737core:RevaluationReserve2024-06-1415779737core:OtherReservesSubtotal2024-06-1415779737core:RetainedEarningsAccumulatedLosses2024-06-1415779737core:LandBuildings2025-03-3115779737core:PlantMachinery2025-03-3115779737core:Vehicles2025-03-3115779737core:FurnitureFittings2025-03-3115779737core:OfficeEquipment2025-03-3115779737core:NetGoodwill2025-03-3115779737core:IntangibleAssetsOtherThanGoodwill2025-03-3115779737core:ListedExchangeTraded2025-03-3115779737core:UnlistedNon-exchangeTraded2025-03-3115779737core:LandBuildings2024-06-1415779737core:PlantMachinery2024-06-1415779737core:Vehicles2024-06-1415779737core:FurnitureFittings2024-06-1415779737core:OfficeEquipment2024-06-1415779737core:NetGoodwill2024-06-1415779737core:IntangibleAssetsOtherThanGoodwill2024-06-1415779737core:ListedExchangeTraded2024-06-1415779737core:UnlistedNon-exchangeTraded2024-06-1415779737core:LandBuildings2024-06-152025-03-3115779737core:PlantMachinery2024-06-152025-03-3115779737core:Vehicles2024-06-152025-03-3115779737core:FurnitureFittings2024-06-152025-03-3115779737core:OfficeEquipment2024-06-152025-03-3115779737core:NetGoodwill2024-06-152025-03-3115779737core:IntangibleAssetsOtherThanGoodwill2024-06-152025-03-3115779737core:ListedExchangeTraded2024-06-152025-03-3115779737core:UnlistedNon-exchangeTraded2024-06-152025-03-3115779737core:MoreThanFiveYears2024-06-152025-03-3115779737core:Non-currentFinancialInstruments2025-03-3115779737core:Non-currentFinancialInstruments2024-06-1415779737dpl:CostSales2024-06-152025-03-3115779737dpl:DistributionCosts2024-06-152025-03-3115779737core:LandBuildings2024-06-152025-03-3115779737core:PlantMachinery2024-06-152025-03-3115779737core:Vehicles2024-06-152025-03-3115779737core:FurnitureFittings2024-06-152025-03-3115779737core:OfficeEquipment2024-06-152025-03-3115779737dpl:AdministrativeExpenses2024-06-152025-03-3115779737core:NetGoodwill2024-06-152025-03-3115779737core:IntangibleAssetsOtherThanGoodwill2024-06-152025-03-3115779737dpl:GroupUndertakings2024-06-152025-03-3115779737dpl:ParticipatingInterests2024-06-152025-03-3115779737dpl:GroupUndertakingscore:ListedExchangeTraded2024-06-152025-03-3115779737core:ListedExchangeTraded2024-06-152025-03-3115779737dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-06-152025-03-3115779737core:UnlistedNon-exchangeTraded2024-06-152025-03-3115779737dpl:CostSales2024-06-142024-06-1415779737dpl:DistributionCosts2024-06-142024-06-1415779737core:LandBuildings2024-06-142024-06-1415779737core:PlantMachinery2024-06-142024-06-1415779737core:Vehicles2024-06-142024-06-1415779737core:FurnitureFittings2024-06-142024-06-1415779737core:OfficeEquipment2024-06-142024-06-1415779737dpl:AdministrativeExpenses2024-06-142024-06-1415779737core:NetGoodwill2024-06-142024-06-1415779737core:IntangibleAssetsOtherThanGoodwill2024-06-142024-06-1415779737dpl:GroupUndertakings2024-06-142024-06-1415779737dpl:ParticipatingInterests2024-06-142024-06-1415779737dpl:GroupUndertakingscore:ListedExchangeTraded2024-06-142024-06-1415779737core:ListedExchangeTraded2024-06-142024-06-1415779737dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-06-142024-06-1415779737core:UnlistedNon-exchangeTraded2024-06-142024-06-1415779737core:NetGoodwill2025-03-3115779737core:IntangibleAssetsOtherThanGoodwill2025-03-3115779737core:LandBuildings2025-03-3115779737core:PlantMachinery2025-03-3115779737core:Vehicles2025-03-3115779737core:FurnitureFittings2025-03-3115779737core:OfficeEquipment2025-03-3115779737core:AfterOneYear2025-03-3115779737core:WithinOneYear2025-03-3115779737core:ListedExchangeTraded2025-03-3115779737core:UnlistedNon-exchangeTraded2025-03-3115779737core:ShareCapital2025-03-3115779737core:SharePremium2025-03-3115779737core:RevaluationReserve2025-03-3115779737core:OtherReservesSubtotal2025-03-3115779737core:RetainedEarningsAccumulatedLosses2025-03-3115779737core:NetGoodwill2024-06-1415779737core:IntangibleAssetsOtherThanGoodwill2024-06-1415779737core:LandBuildings2024-06-1415779737core:PlantMachinery2024-06-1415779737core:Vehicles2024-06-1415779737core:FurnitureFittings2024-06-1415779737core:OfficeEquipment2024-06-1415779737core:AfterOneYear2024-06-1415779737core:WithinOneYear2024-06-1415779737core:ListedExchangeTraded2024-06-1415779737core:UnlistedNon-exchangeTraded2024-06-1415779737core:ShareCapital2024-06-1415779737core:SharePremium2024-06-1415779737core:RevaluationReserve2024-06-1415779737core:OtherReservesSubtotal2024-06-1415779737core:RetainedEarningsAccumulatedLosses2024-06-1415779737core:NetGoodwill2024-06-1315779737core:IntangibleAssetsOtherThanGoodwill2024-06-1315779737core:LandBuildings2024-06-1315779737core:PlantMachinery2024-06-1315779737core:Vehicles2024-06-1315779737core:FurnitureFittings2024-06-1315779737core:OfficeEquipment2024-06-1315779737core:AfterOneYear2024-06-1315779737core:WithinOneYear2024-06-1315779737core:ListedExchangeTraded2024-06-1315779737core:UnlistedNon-exchangeTraded2024-06-1315779737core:ShareCapital2024-06-1315779737core:SharePremium2024-06-1315779737core:RevaluationReserve2024-06-1315779737core:OtherReservesSubtotal2024-06-1315779737core:RetainedEarningsAccumulatedLosses2024-06-1315779737core:AfterOneYear2024-06-152025-03-3115779737core:WithinOneYear2024-06-152025-03-3115779737core:Non-currentFinancialInstrumentscore:CostValuation2024-06-152025-03-3115779737core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-06-152025-03-3115779737core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-06-152025-03-3115779737core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-06-152025-03-3115779737core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-06-152025-03-3115779737core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-06-152025-03-3115779737core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-06-152025-03-3115779737core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-06-152025-03-3115779737core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-06-152025-03-3115779737core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3115779737core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3115779737core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3115779737core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3115779737core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3115779737core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3115779737core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3115779737core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3115779737core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3115779737core:Non-currentFinancialInstrumentscore:CostValuation2024-06-1415779737core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-06-1415779737core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-06-1415779737core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-06-1415779737core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-06-1415779737core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-06-1415779737core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-06-1415779737core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-06-1415779737core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-06-1415779737bus:Director12024-06-152025-03-31

SCULPTCLINIC LTD

Registered Number
15779737
(England and Wales)

Unaudited Financial Statements for the Period ended
31 March 2025

SCULPTCLINIC LTD
Company Information
for the period from 15 June 2024 to 31 March 2025

Director

ALLY, Zack, Dr

Registered Address

Cortlandt, George Street, Hailsham, East Sussex
George Street
Hailsham
BN27 1AE

Registered Number

15779737 (England and Wales)
SCULPTCLINIC LTD
Balance Sheet as at
31 March 2025

Notes

2025

£

£

Fixed assets
Tangible assets3201
201
Current assets
Debtors81,788
Cash at bank and on hand863,941
945,729
Creditors amounts falling due within one year4(317,390)
Net current assets (liabilities)628,339
Total assets less current liabilities628,540
Net assets628,540
Capital and reserves
Called up share capital1
Profit and loss account628,539
Shareholders' funds628,540
The financial statements were approved and authorised for issue by the Director on 22 December 2025, and are signed on its behalf by:
ALLY, Zack, Dr
Director
Registered Company No. 15779737
SCULPTCLINIC LTD
Notes to the Financial Statements
for the period ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Office Equipment299.98
2.Average number of employees

2025
Average number of employees during the year0
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
Additions300300
At 31 March 25300300
Depreciation and impairment
Charge for year9999
At 31 March 259999
Net book value
At 31 March 25201201
At 14 June 24--
4.Creditors: amounts due within one year

2025

£
Trade creditors / trade payables4,264
Taxation and social security255,480
Accrued liabilities and deferred income57,646
Total317,390
5.Related party transactions
Included within current assets is an interest bearing loan to director Dr Z Ally, advanced in year £57,567, as at 31/03/2025 £57,567